UID,Searchword,API,URL,Title,Summary,Article,Title_Sentiment,Title_Positive,Title_Neutral,Title_Negative,Article_Sentiment,Article_Positive,Article_Neutral,Article_Negative,Verified,Language,Topics,Date,Load_Date,Source
5111,Clearstream,Twitter API,Twitter,Save $20 for a limited time on the ClearStream 4MAX and ClearStream 2MAX at @BestBuy! Sale ends 5/28. Shop now!‚Ä¶ https://t.co/jyw7KYpsLf,nan,Save $20 for a limited time on the ClearStream 4MAX and ClearStream 2MAX at @BestBuy! Sale ends 5/28. Shop now!‚Ä¶ https://t.co/jyw7KYpsLf,neutral,0.07,0.91,0.02,neutral,0.07,0.91,0.02,True,English,"['limited time', 'ClearStream 4MAX', 'Sale', 'Shop', 'jyw7KYpsLf', 'limited time', 'ClearStream 4MAX', 'Sale', 'Shop', 'jyw7KYpsLf']",2022-05-18,2022-05-22,Unknown
5112,Clearstream,Twitter API,Twitter,Coming up at ETF Ecosystem Unwrapped 2022  day 2...Allan Stewart of @Clearstream sits down with Senior ETF Stream‚Ä¶ https://t.co/kWvbXjCNCp,nan,Coming up at ETF Ecosystem Unwrapped 2022  day 2...Allan Stewart of @Clearstream sits down with Senior ETF Stream‚Ä¶ https://t.co/kWvbXjCNCp,neutral,0.02,0.94,0.03,neutral,0.02,0.94,0.03,True,English,"['Senior ETF Stream', 'ETF Ecosystem', 'Allan Stewart', 'day', 'kWvbXjCNCp', 'Senior ETF Stream', 'ETF Ecosystem', 'Allan Stewart', 'day', 'kWvbXjCNCp']",2022-05-18,2022-05-22,Unknown
5113,Clearstream,Twitter API,Twitter,@garaysoccer10 clearstream szn ???,nan,@garaysoccer10 clearstream szn ???,neutral,0.04,0.91,0.05,neutral,0.04,0.91,0.05,True,English,"['garaysoccer10 clearstream szn', 'garaysoccer10 clearstream szn']",2022-05-18,2022-05-22,Unknown
5187,Clearstream,Twitter API,Twitter,Antennas Direct ClearStream 2MAX Review‚ñ∏ https://t.co/siaLGwUJbZ#KeyHighlight #BigSize #BoldDesign‚Ä¶ https://t.co/yJlNlIxINh,nan,Antennas Direct ClearStream 2MAX Review‚ñ∏ https://t.co/siaLGwUJbZ#KeyHighlight #BigSize #BoldDesign‚Ä¶ https://t.co/yJlNlIxINh,neutral,0.05,0.94,0.01,neutral,0.05,0.94,0.01,True,English,"['ClearStream 2MAX Review', 'BigSize #BoldDesign', 'Antennas', 'siaLGwUJbZ', 'KeyHighlight', 'ClearStream 2MAX Review', 'BigSize #BoldDesign', 'Antennas', 'siaLGwUJbZ', 'KeyHighlight']",2022-05-19,2022-05-22,Unknown
5188,Clearstream,Twitter API,Twitter,üìÜ #Clearstream Chairman Stephan Leithner will join this year‚Äôs virtual #WFC22 to share his ‚ÄúVision for the industry‚Ä¶ https://t.co/KtAUNJzhBF,nan,üìÜ #Clearstream Chairman Stephan Leithner will join this year‚Äôs virtual #WFC22 to share his ‚ÄúVision for the industry‚Ä¶ https://t.co/KtAUNJzhBF,neutral,0.06,0.92,0.02,neutral,0.06,0.92,0.02,True,English,"['virtual #WFC22', 'year', 'Vision', 'industry', 'KtAUNJzhBF', 'virtual #WFC22', 'year', 'Vision', 'industry', 'KtAUNJzhBF']",2022-05-19,2022-05-22,Unknown
5189,Clearstream,Twitter API,Twitter,@DeutscheBoerse and Clearstream have co-developed a new data service as they recognise data as a growth point for t‚Ä¶ https://t.co/pr32Pvm50W,nan,@DeutscheBoerse and Clearstream have co-developed a new data service as they recognise data as a growth point for t‚Ä¶ https://t.co/pr32Pvm50W,neutral,0.04,0.95,0.01,neutral,0.04,0.95,0.01,True,English,"['new data service', 'growth point', 'Clearstream', 'pr32Pvm50W', 'new data service', 'growth point', 'Clearstream', 'pr32Pvm50W']",2022-05-19,2022-05-22,Unknown
5314,EuroNext,Twitter API,Twitter,1/ #VERSITY is powered by @agencesdepapa: the first digital real estate agency in France  listed on Euronext with‚Ä¶ https://t.co/QwdwVYIM4C,nan,1/ #VERSITY is powered by @agencesdepapa: the first digital real estate agency in France  listed on Euronext with‚Ä¶ https://t.co/QwdwVYIM4C,neutral,0.03,0.95,0.02,neutral,0.03,0.95,0.02,True,English,"['first digital real estate agency', 'France', 'Euronext', 'QwdwVYIM4C', 'first digital real estate agency', 'France', 'Euronext', 'QwdwVYIM4C']",2022-05-21,2022-05-22,Unknown
5315,EuroNext,Twitter API,Twitter,Saturday Special: Why the London Stock Exchange and Euronext are moving their datacentres around https://t.co/ZiL6yxKDVr,nan,Saturday Special: Why the London Stock Exchange and Euronext are moving their datacentres around https://t.co/ZiL6yxKDVr,neutral,0.05,0.9,0.05,neutral,0.05,0.9,0.05,True,English,"['London Stock Exchange', 'Saturday', 'Euronext', 'datacentres', 'co', 'ZiL6yxKDVr', 'London Stock Exchange', 'Saturday', 'Euronext', 'datacentres', 'co', 'ZiL6yxKDVr']",2022-05-21,2022-05-22,Unknown
5316,EuroNext,Twitter API,Twitter,@vs_traders Euronext ?,nan,@vs_traders Euronext ?,neutral,0.04,0.91,0.05,neutral,0.04,0.91,0.05,True,English,"['vs_traders Euronext', 'vs_traders Euronext']",2022-05-21,2022-05-22,Unknown
5317,EuroNext,Twitter API,Twitter,Today we mark the World Day for Cultural Diversity! At Euronext  we know first-hand how a mix of cultures and backg‚Ä¶ https://t.co/bFmFgkNVF1,nan,Today we mark the World Day for Cultural Diversity! At Euronext  we know first-hand how a mix of cultures and backg‚Ä¶ https://t.co/bFmFgkNVF1,neutral,0.1,0.87,0.03,neutral,0.1,0.87,0.03,True,English,"['World Day', 'Cultural Diversity', 'Euronext', 'mix', 'cultures', 'backg', 'bFmFgkNVF1', 'World Day', 'Cultural Diversity', 'Euronext', 'mix', 'cultures', 'backg', 'bFmFgkNVF1']",2022-05-21,2022-05-22,Unknown
5318,EuroNext,Twitter API,Twitter,Exclusive: Why the London Stock Exchange and Euronext are moving their datacentres around https://t.co/i7cVgOGHsd,nan,Exclusive: Why the London Stock Exchange and Euronext are moving their datacentres around https://t.co/i7cVgOGHsd,neutral,0.06,0.91,0.03,neutral,0.06,0.91,0.03,True,English,"['London Stock Exchange', 'Euronext', 'datacentres', 'i7cVgOGHsd', 'London Stock Exchange', 'Euronext', 'datacentres', 'i7cVgOGHsd']",2022-05-21,2022-05-22,Unknown
5321,Clearstream,Google API,https://thedailyvale.com/2022/05/22/peripheral-vascular-devices-market-growth-2022-2030-medtronic-inc-jotec-gmbh/,Peripheral Vascular Devices Market Growth 2022-2030 ...,19 hours ago,This major report presents a clear view of how global Peripheral Vascular Devices market is performing today and how it will probably evolve in the years ahead. The key findings in the report on global Peripheral Vascular Devices market are focused on the changing global Peripheral Vascular Devices market dynamics  substantial new opportunities  critical forces that are likely to contribute to the growth of global Peripheral Vascular Devices market both in advanced and developing economies.This report centers about the top players in global Peripheral Vascular Devices marketplace:Medtronic  Inc.  Jotec GmbH  Terumo Corporation  Angiomed GmbH ÔºÜCo. Medizintechnik KG  Bolton Medical  Inc.  Abbott Laboratories Vascular Enterprises Limited  Aesculap AG  William Cook Europe ApS  ENDOLOGIX  Inc.  ClearStream Technologies Ltd.  Bioteq  Boston Scientific Corporation  Microport  curative medical devices gmbh  Lepu ‚Ä¶Get FREE PDF Sample Copy of the Report @ https://marketstrides.com/request-sample/peripheral-vascular-devices-marketThe report undertakes research and analysis that helps market players understand the state of global Peripheral Vascular Devices market in advanced and developing economies  future market scenarios  opportunities  and identify solutions on how to organize and operate in the global Peripheral Vascular Devices market. The report starts with examining how the global Peripheral Vascular Devices market has evolved through the pandemic to this the post-pandemic point  key forces at work  implications of covid-19 pandemic on companies and policy-makers. Most importantly  the report has conducted deep dive analysis of the selected segments and countries.Detailed analysis of the capital intensive market companies  their strategic trends and their impacts on production and growth of the industry are studied in the report. The focus of the report is to present the forces that would have impact on different parts of today‚Äôs global Peripheral Vascular Devices industry. The report aims to map out the risks facing different regions  countries  and segments operating in the market as well as provides range of options and responses. It recommends best practices to improve efficiency  protect against future risks as well as supply chains from possible threats. Finally  the report helps the market players to anticipate trends and capture market opportunities with the data and forecasts given in the report.Peripheral Vascular Devices industry: Main Product Form :Peripheral vascular stents  PTA balloon catheter  Embolic protection device  Aortic stent graft  Surgical artificial transplantApplications that contain:The treatment of peripheral blood vessels damaged  The treatment of peripheral blood vessels blockageGlobal Peripheral Vascular Devices Market research report offers‚Äì‚Äî The report discusses the major mergers and acquisitions  organic investments including R&D.‚Äî The report presents a study on the response of the leading manufacturers to understand elasticity in target markets.‚Äî The report provides a detailed assessment of the long-term global Peripheral Vascular Devices market outlook.‚Äî The report assesses the global Peripheral Vascular Devices market business segments  products  services  and supply channels.‚Äî The report highlights the challenges faced by the global Peripheral Vascular Devices market players in expanding new sectors  trading of certain goods or products during pandemic  and expanding in new consumer segments.‚Äî The report highlights both opportunities and threat that are shaping the global Peripheral Vascular Devices market particularly the consumer segments.‚Äî The report discusses the financial structure of the global Peripheral Vascular Devices market  business and operating models.‚Äî The report identifies the innovation strategies adopted by well-established firms in the global Peripheral Vascular Devices market.Key questions answered in the report include:Which are the new manufacturers highly focused on growth and are likely to achieve aggressive growth in the years ahead?Which is the largest geography in the global Peripheral Vascular Devices market?How has the pandemic diversely impacted the GDP of the global Peripheral Vascular Devices market across the selected countries?What are global economic prospects of the Peripheral Vascular Devices industry?What are the performance indicators of the Peripheral Vascular Devices industry between 2019 and 2020?How are market players recovering from the covid-19 pandemic?What is the road to recovery from the covid crisis?About Us:Market Strides is a Global aggregator and publisher of Market intelligence development reports  equity reports  database directories  and economic reports. Our repository is diverse  spanning virtually every industrial sector and even more every category and sub-category within the industry.Our pre-onboarding strategy for publishers is perhaps  what makes us stand out in the market space. Publishers & their market Share  reports are meticulously validated by our in-house panel of consultants  prior to a feature on our website. These in-house panel of consultants are also in charge of ensuring that our website features the most updated reports only.Have Any Query? Ask Our ExpertsMarket Strides have team of professionals that assist you in many advanced industry specific trends  content and tests different strategies and implements the most productive one for the business.For more information  Email ‚Äì [email protected]Contact Us: +1 856 677 8909 (US)Direct Purchase ReportFollow us on Social Media:Other Reports:https://marketstrides.com/report/windscreen-wiper-blade-markethttps://marketstrides.com/report/anti-depressant-drugs-markethttps://marketstrides.com/report/high-performance-brake-system-markethttps://marketstrides.com/report/ultrasonic-level-meter-market,neutral,0.01,0.98,0.01,mixed,0.15,0.33,0.52,True,English,"['Peripheral Vascular Devices', 'Market Growth', 'changing global Peripheral Vascular Devices market dynamics', 'long-term global Peripheral Vascular Devices market outlook', 'Global Peripheral Vascular Devices Market research report', 'global Peripheral Vascular Devices market players', 'global Peripheral Vascular Devices marketplace', 'Abbott Laboratories Vascular Enterprises Limited', 'global Peripheral Vascular Devices industry', 'William Cook Europe ApS', 'FREE PDF Sample Copy', 'peripheral blood vessels blockage', 'curative medical devices gmbh', 'capital intensive market companies', 'Market intelligence development reports', 'Peripheral vascular stents', 'global economic prospects', 'future market scenarios', 'ClearStream Technologies Ltd.', 'Main Product Form', 'PTA balloon catheter', 'Embolic protection device', 'Aortic stent graft', 'Surgical artificial transplant', 'Boston Scientific Corporation', 'deep dive analysis', 'substantial new opportunities', 'Global aggregator', 'new consumer segments', 'Market Strides', 'market space', 'market Share', 'market opportunities', 'Bolton Medical', 'top players', 'economic reports', 'Jotec GmbH', 'Angiomed GmbH', 'Terumo Corporation', 'new sectors', 'new manufacturers', 'equity reports', 'clear view', 'key findings', 'developing economies', 'Aesculap AG', 'post-pandemic point', 'Detailed analysis', 'different parts', 'different regions', 'best practices', 'future risks', 'supply chains', 'possible threats', 'major mergers', 'organic investments', 'R&D.', 'leading manufacturers', 'target markets', 'detailed assessment', 'supply channels', 'financial structure', 'operating models', 'innovation strategies', 'Key questions', 'largest geography', 'performance indicators', 'covid crisis', 'database directories', 'industrial sector', 'onboarding strategy', 'house panel', 'critical forces', 'key forces', 'strategic trends', 'covid-19 pandemic', 'major report', 'business segments', 'aggressive growth', 'years', 'advanced', 'Medtronic', 'ENDOLOGIX', 'Inc.', 'Bioteq', 'Microport', 'Lepu', 'marketstrides', 'request-sample', 'peripheral-vascular-devices-market', 'state', 'solutions', 'work', 'implications', 'policy-makers', 'countries', 'impacts', 'production', 'focus', 'today', 'range', 'options', 'responses', 'efficiency', 'forecasts', 'Applications', 'treatment', 'acquisitions', 'study', 'elasticity', 'products', 'services', 'challenges', 'goods', 'firms', 'GDP', 'road', 'recovery', 'publisher', 'repository', 'category']",2022-05-22,2022-05-22,thedailyvale.com
5322,Clearstream,Twitter API,Twitter,@LeSommierRgis Une forme de petite Clearstream...,nan,@LeSommierRgis Une forme de petite Clearstream...,neutral,0.07,0.88,0.05,neutral,0.07,0.88,0.05,True,English,"['petite Clearstream', 'LeSommierRgis', 'forme', 'petite Clearstream', 'LeSommierRgis', 'forme']",2022-05-21,2022-05-22,Unknown
5323,EuroNext,NewsApi.org,https://www.totaltele.com/513261/Kerlink-and-partners-demonstrate-IoT-air-quality-monitoring-contact-tracing-system-that-shows-promise-for-controlling-viruses-spread,Kerlink and partners demonstrate IoT air-quality monitoring & contact-tracing system that shows promise for controlling viruses' spread - Total Telecom,Kerlink and Partners Deploy Internet of Things Project That Demonstrates How Building Owners Can Help Limit Covid-19 Transmission &amp; Future Outbreaks of‚Ä¶,Kerlink and Partners Deploy Internet of Things Project That Demonstrates How Building Owners Can Help Limit Covid-19 Transmission & Future Outbreaks of VirusesMay 5  2022  06:00 p.m. CEST ‚Äì Combining off-the-shelf IoT technologies and equipment with new mathematical models that simulated the propagation of Covid-19  a pilot solution at a leading Paris university hospital center has demonstrated how building managers in the future can limit the spread of viruses such as Covid-19.The eight-month trial in 2021 included nearly 200 students and about 20 staff volunteers who wore Bluetooth-enabled badges during their classes  labs and shifts at the Faculty of Medicine (medical school) at Kremlin-Bic√™tre AP-HP (Assistance Publique-H√¥pitaux de Paris).In addition to continuous monitoring of building air-quality  the system monitored occupants‚Äô movements and whereabouts using dedicated mathematical models developed by two Paris-Saclay University scientists. These models simulated the propagation of Covid-19 in the student population  based on contact-tracing matrices.‚ÄúThis made it possible to investigate the importance of actual contacts between individuals in the transmission process  and more generally to estimate the role of the population‚Äôs actions  such as gathering in ill-ventilated rooms and the length and type of communication ‚Äì casual short conversation or longer collaboration ‚Äì between individuals in the overall spread of the epidemic ‚Äù said Bertrand Maury  who along with colleague Sylvain Faure  created the algorithms. ‚ÄúThis evaluation clearly showed this IoT-based solution can help building managers in the future to limit the spread of viruses such as Covid-19.‚ÄùThe contact-tracing application in the buildings was paired with air-quality monitoring that included:‚Ä¢ CO2 levels in the premises in relation to occupancy rates and hours  and ventilation adjustments ‚Ä¢ Malfunctions in the ventilation or required maintenance of ventilation equipment  and‚Ä¢ Hourly renewal rate (HRR)  or complete renewal of the air in a room  which is a key performance indicator (KPI) monitored by building managers in their day-to-day operations.The contact-tracing matrices were inspired by an algorithm developed by France‚Äôs National Center for Scientific Research (CNRS) and Paris-Saclay University that defines epidemiological models for virus transmission. It also provides a first assessment of the influence of CO2 concentration as an indicator of poor air quality that may accelerate viral transmission  e.g. a CO2 level indicating insufficient indoor air renewal.The pilot project at Kremlin-Bic√™tre AP-HP has been validated by the clinical research unit of the Paris-Saclay Faculty of Medicine  while the protection of private data and the identities of the pilot-project participants fully complied with GDPR law.Prof. Olivier Lambotte  vice dean of the Faculty of Medicine at Kremlin-Bic√™tre AP-HP  said Covid-19 virus transmission and the desire to develop an ‚Äúimproved-alerting‚Äù tool based on epidemiologic models were the initial triggers for this demonstrator project and they have been successfully completed with air-quality monitoring through CO2-level analysis.‚ÄúAfter these initial results  the Faculty of Medicine will be able to refine its systems for combatting the spread of epidemics thanks to a better knowledge of the interactions between students and thanks to a mastery of air quality ‚Äù he said. ‚ÄúMathematical modeling of air renewal in a classroom or amphitheater allows us to estimate in advance the maximum number of people who can be present to maintain a CO2 level below a set threshold.‚ÄùThe system used technology jointly developed by Kerlink (AKLK ‚Äì FR0013156007)  a specialist in solutions dedicated to the Internet of Things (IoT)  Microshare  a provider of a leading data-management solutions for the IoT era  and Enless Wireless  a major manufacturer of intelligent self-powered sensors  communicating in radio mode and dedicated to energy performance & comfort applications in buildings.The LoRaWAN-based system used Kerlink Wanesy‚Ñ¢ Wave  a multi-purpose powered anchor ‚Äì combining Wi-Fi  BLE and LoRaWAN¬Æ  for contact-tracing data collection from Bluetooth badges ‚Äì and a Kerlink Wirnet‚Ñ¢ iFemtoCell indoor gateway to transmit the data to Microshare‚Äôs Universal Contact Tracing¬Æ application  which ensures end-to-end security  privacy and reliability for the delivery of critical information where it‚Äôs needed. The data it produces is GDPR-compliant and delivered through Microshare‚Äôs patent-pending rules and sharing engine to only appropriate  designated people in the organization at the right time. Enless Wireless provided the pilot project with easy-to-install and connect indoor air-quality transmitters with embedded CO2 sensors and high-performance D-type batteries.LoRa Alliance¬Æ and LoRaWAN¬Æ are marks used under license from the LoRa Alliance¬Æ.About KerlinkKerlink Group is a leading global provider of end-to-end connectivity solutions for designing  deploying  and operating public & private low power/wide area (LPWA) Internet of Things (IoT) networks. Its comprehensive product portfolio includes industrial-grade network equipment  best-of-breed network core  operations and management software  value-added applications and expert professional services  backed by strong R&D capabilities. Kerlink specializes in enabling future-proof intelligent IoT connectivity for three major domains: Smart City & Quality of Life ‚Äì urban operations  utilities & metering  retail & public places  infrastructure & hubs  health; Smart Building & Industry ‚Äì buildings & real estate  industry & manufacturing  asset monitoring & tracking  and Smart Agriculture & Environment ‚Äì precision agriculture  cattle monitoring & farming  environment & climate  and wildlife protection. More than 200 000 Kerlink installations have been rolled out with over 350 clients in 70 countries. Based in France  with subsidiaries in the US  Singapore  India and Japan  Kerlink is a co-founder and board member of the LoRa Alliance¬Æ and the uCIFI Alliance‚Ñ¢. It is listed on Euronext Growth Paris under the symbol ALKLK.For more information  visit www.kerlink.com or follow us on our social media - Twitter @kerlink_news  LinkedIn #Kerlink  YouTube ‚Äì KerlinkAbout MicroshareMicroshare¬Æ provides Smart Building data solutions at scale that enhance safety  wellness and sustainability  and drive cost savings and efficiencies across the world. Our EverSmart suite of solutions produces real-time insights where none previously existed in areas such as occupancy monitoring  energy consumption  customer satisfaction  environmental safety and more. Microshare is a proud member of the LoRa Alliance¬Æ. www.microshare.ioAbout Enless WirelessEnless Wireless is a leading automation and IoT French player in building energy efficiency & comfort for more than 12 years. It manufactures a catalogue of wireless radio sensors  based on the main LPWAN radio protocols LoRa  Sigfox  Wireless M-Bus. With Enless Wireless‚Äôs range of standalone wireless sensors LoRaWAN¬Æ  European system integrators can quickly and simply build their own private network using BACnet or Modbus protocols to connect to an PLC or their building‚Äôs IP network.Enless Wireless also manufactures ranges of Sigfox and LoRaWAN¬Æ devices which allow system integrators to build operated networks. Effective monitoring of the energy consumption  CO2  VOC  temperature ... with Low-Power / Ultra Long-Range products that are quick and easy to install is the first step to guarantee the safety and comfort of building‚Äôs occupants ... and the optimization of the energy bill!For more information  visit https://enless-wireless.com/en/(Enless Wireless is a certified ISO 9001 company)View more of the latest press releases from across the industry or post your company's news.,neutral,0.03,0.95,0.02,mixed,0.27,0.13,0.6,True,English,"['IoT air-quality monitoring', 'contact-tracing system', ""viruses' spread"", 'Total Telecom', 'Kerlink', 'partners', 'promise', 'Assistance Publique-H√¥pitaux de Paris', 'Kerlink Wirnet‚Ñ¢ iFemtoCell indoor gateway', 'leading Paris university hospital center', 'Universal Contact Tracing¬Æ application', 'two Paris-Saclay University scientists', 'insufficient indoor air renewal', 'Kremlin-Bic√™tre AP-HP', 'casual short conversation', 'colleague Sylvain Faure', 'Prof. Olivier Lambotte', 'leading data-management solutions', 'intelligent self-powered sensors', 'multi-purpose powered anchor', 'indoor air-quality transmitters', 'high-performance D-type batteries', 'Hourly renewal rate', 'leading global provider', 'clinical research unit', 'embedded CO2 sensors', 'Kerlink Wanesy‚Ñ¢ Wave', 'appropriate, designated people', 'poor air quality', 'new mathematical models', 'dedicated mathematical models', 'The LoRaWAN-based system', 'key performance indicator', 'end connectivity solutions', 'contact-tracing data collection', 'Covid-19 virus transmission', 'National Center', 'contact-tracing application', 'complete renewal', 'Mathematical modeling', 'Scientific Research', 'energy performance', 'contact-tracing matrices', 'Covid-19 Transmission', 'transmission process', 'CO2 levels', 'epidemiological models', 'CO2 concentration', 'viral transmission', 'epidemiologic models', 'Kerlink Group', 'pilot solution', 'eight-month trial', '20 staff volunteers', 'Bluetooth-enabled badges', 'medical school', 'continuous monitoring', 'occupants‚Äô movements', 'actual contacts', 'ill-ventilated rooms', 'longer collaboration', 'Bertrand Maury', 'IoT-based solution', 'air-quality monitoring', 'occupancy rates', 'first assessment', 'pilot project', 'pilot-project participants', 'GDPR law', 'vice dean', 'alerting‚Äù tool', 'initial triggers', 'demonstrator project', 'CO2-level analysis', 'initial results', 'maximum number', 'set threshold', 'Enless Wireless', 'major manufacturer', 'radio mode', 'comfort applications', 'Bluetooth badges', 'end security', 'critical information', 'patent-pending rules', 'right time', 'LoRa Alliance¬Æ', 'private l', 'Paris-Saclay Faculty', 'Building Owners', 'private data', 'IoT technologies', 'ventilation adjustments', 'IoT era', 'Things Project', 'student population', 'day operations', 'building managers', 'Future Outbreaks', 'overall spread', 'ventilation equipment', 'Partners', 'Internet', 'Viruses', 'CEST', 'shelf', 'propagation', '200 students', 'classes', 'labs', 'shifts', 'Medicine', 'addition', 'whereabouts', 'importance', 'individuals', 'role', 'actions', 'length', 'communication', 'epidemic', 'algorithms', 'evaluation', 'buildings', 'premises', 'relation', 'hours', 'Malfunctions', 'maintenance', 'HRR', 'KPI', 'France', 'CNRS', 'influence', 'protection', 'identities', 'desire', 'improved', 'systems', 'knowledge', 'mastery', 'classroom', 'amphitheater', 'advance', 'technology', 'AKLK', 'specialist', 'Microshare', 'Wi-Fi', 'LoRaWAN¬Æ', 'privacy', 'reliability', 'delivery', 'engine', 'organization', 'marks', 'license', 'public', '06:00']",2022-05-21,2022-05-22,totaltele.com
5324,EuroNext,Google API,https://simplywall.st/stocks/fr/diversified-financials/epa-enx/euronext-shares/news/euronext-epaenx-is-increasing-its-dividend-to-193,Euronext (EPA:ENX) Is Increasing Its Dividend To ‚Ç¨1.93,14 hours ago,The board of Euronext N.V. ( ) has announced that it will be increasing its dividend on the 25th of May to ‚Ç¨1.93. Although the dividend is now higher  the yield is only 2.4%  which is below the industry average.Euronext's Payment Has Solid Earnings CoverageIf it is predictable over a long period  even low dividend yields can be attractive. Prior to this announcement  Euronext's dividend was comfortably covered by both cash flow and earnings. This indicates that a lot of the earnings are being reinvested into the business  with the aim of fueling growth.Over the next year  EPS is forecast to expand by 2.9%. If the dividend continues on this path  the payout ratio could be 46% by next year  which we think can be pretty sustainable going forward.ENXTPA:ENX Historic Dividend May 22nd 2022Euronext Doesn't Have A Long Payment HistoryIt is great to see that Euronext has been paying a stable dividend for a number of years now  however we want to be a bit cautious about whether this will remain true through a full economic cycle. The dividend has gone from ‚Ç¨0.84 in 2015 to the most recent annual payment of ‚Ç¨1.93. This works out to be a compound annual growth rate (CAGR) of approximately 13% a year over that time. Euronext has been growing its dividend quite rapidly  which is exciting. However  the short payment history makes us question whether this performance will persist across a full market cycle.We Could See Euronext's Dividend GrowingInvestors who have held shares in the company for the past few years will be happy with the dividend income they have received. Euronext has impressed us by growing EPS at 9.2% per year over the past five years. Since earnings per share is growing at an acceptable rate  and the payout policy is balanced  we think the company is positioning itself well to grow earnings and dividends in the future.We Really Like Euronext's DividendOverall  a dividend increase is always good  and we think that Euronext is a strong income stock thanks to its track record and growing earnings. The company is easily earning enough to cover its dividend payments and it is great to see that these earnings are being translated into cash flow. All of these factors considered  we think this has solid potential as a dividend stock.Investors generally tend to favour companies with a consistent  stable dividend policy as opposed to those operating an irregular one. Meanwhile  despite the importance of dividend payments  they are not the only factors our readers should know when assessing a company. As an example  we've identified that you should be aware of before investing. If you are a dividend investor  you might also want to look at ourHave feedback on this article? Concerned about the content? with us directly. Alternatively  email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock  and does not take account of your objectives  or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.,neutral,0.01,0.97,0.02,mixed,0.43,0.2,0.37,True,English,"['Euronext', 'EPA', 'ENX', 'Dividend', 'latest price-sensitive company announcements', 'compound annual growth rate', 'consistent, stable dividend policy', 'full economic cycle', 'recent annual payment', 'full market cycle', 'Simply Wall St', 'short payment history', 'Long Payment History', 'long-term focused analysis', 'low dividend yields', 'ENX Historic Dividend', 'strong income stock', 'Euronext N.V.', 'Solid Earnings Coverage', 'past five years', 'acceptable rate', 'payout policy', 'long period', 'solid potential', 'dividend income', 'industry average', 'cash flow', 'payout ratio', 'track record', 'irregular one', 'historical data', 'analyst forecasts', 'unbiased methodology', 'financial advice', 'financial situation', 'fundamental data', 'qualitative material', 'Dividend Growing', 'dividend increase', 'dividend payments', 'dividend stock', 'dividend investor', 'next year', 'growing earnings', 'board', '25th', 'May', 'lot', 'business', 'aim', 'EPS', 'path', 'ENXTPA', 'number', 'CAGR', 'time', 'performance', 'Investors', 'shares', 'dividends', 'future', 'factors', 'companies', 'importance', 'readers', 'example', 'feedback', 'article', 'content', 'editorial-team', 'simplywallst', 'nature', 'commentary', 'recommendation', 'account', 'objectives', 'position', 'stocks', '2.']",2022-05-22,2022-05-22,simplywall.st
5325,EuroNext,Google API,https://www.brecorder.com/news/40174741,Paris wheat,1 day ago,PARIS: Euronext wheat extended a pullback on Friday from near-record highs earlier this week  pressured by a further slide in Chicago and reports that India could ease an export ban. Over the week  the contract was up 1%  having given up most of its gains since Tuesday‚Äôs peak of 444.50 euros that was a life-of-contract high and near an all-time peak of 450 euros for Euronext. Chicago wheat also fell for a third straight session to a one-week low.India is considering allowing traders to ship out wheat sitting at ports after a sudden ban on exports prevented dealers from loading cargoes  Reuters reported on Thursday.,neutral,0.11,0.84,0.05,negative,0.02,0.19,0.79,True,English,"['Paris wheat', 'third straight session', 'record highs', 'export ban', 'one-week low', 'sudden ban', 'time peak', 'Euronext wheat', 'Chicago wheat', 'PARIS', 'pullback', 'Friday', 'slide', 'reports', 'India', 'contract', 'gains', 'Tuesday', '444.50 euros', 'life', '450 euros', 'traders', 'exports', 'dealers', 'cargoes', 'Reuters', 'Thursday']",2022-05-22,2022-05-22,brecorder.com
5326,EuroNext,Google API,http://www.parabolicarc.com/2022/05/22/eutelsat-reports-third-quarter-and-nine-month-revenues-of-e285-million/,Eutelsat Reports Third Quarter and Nine-month Revenues of ‚Ç¨285 Million ‚Äì Parabolic Arc,4 hours ago,Eutelsat quantum satellite (Credit: Airbus)Third Quarter Operating Verticals revenues of ‚Ç¨285m -3.5% 1 year-on-year -0.7% 1 quarter-on-quarterBroadly stable Broadcast revenues quarter-on-quarterStrong growth in Fixed Broadband and Mobile ConnectivityNine Month operating vertical revenues down 4.0% 1 year-on-year  in line with expectationsyear-on-year  in line with expectations All financial objectives confirmedPARIS  12 May 2022 (Eutelsat PR) ‚Äì Eutelsat Communications (ISIN: FR0010221234 ‚Äì Euronext Paris: ETL) reports revenues for the Third Quarter and Nine Months ended 31 March 2022.Eva Berneke  Chief Executive Officer of Eutelsat Communications  said: ‚ÄúThe Third Quarter saw robust delivery  with an improvement in Broadcast trend and strong double-digit growth in both Fixed Broadband and Mobile Connectivity whereas Government Services inevitably reflected the geopolitical environment in the Middle East. Recent months have seen meaningful progress on the commercial front in particular with the successful commercialization of EUTELSAT QUANTUM. Elsewhere  our global distribution agreement with OneWeb to address key connectivity verticals enhances the competitive position of both companies and represents a first step towards the development of combined GEO/LEO solutions. Overall  revenues at the Nine Month stage are in line with our expectations  and we confirm all our financial objectives.‚ÄùHIGHLIGHTSThird Quarter operating vertical revenues of ‚Ç¨285m  broadly stable (-0.7%) quarter-on-quarter.Improvement in Broadcast revenue trend (-6.8% year-on-year in the Third Quarter after 8.6% in the second quarter) with Third Quarter revenues broadly stable (-0.8%) relative to the Second Quarter.Robust double-digit growth for both Fixed Broadband and Mobile Connectivity in the Third Quarter  at respectively circa plus 30% and plus 25% year-on-year  highlighting the significant potential in Connectivity.Strong progress in the commercialization of EUTELSAT QUANTUM with six beams (out of eight) already sold after six months of operation and the entire capacity expected to be fully sold in the coming months.Global distribution partnership secured with OneWeb to address key connectivity verticals  deepening cooperation and showcasing operational synergies between the two companies.Nine Month Operating Verticals of ‚Ç¨853m down 4.0% year-on-year and in line with expectations  enabling us to reiterate our objective for the Full Year of between ‚Ç¨1 110 million and ‚Ç¨1 130 million 4 .. All other financial objectives also confirmed.THIRD QUARTER REVENUES5Total revenues for the Third Quarter stood at ‚Ç¨287 million down 4.8% on a reported basis and by 2.7% like-for-like.Revenues of the five Operating Verticals (ie  excluding ‚ÄòOther Revenues‚Äô) stood at ‚Ç¨285 million. They were down by 3.5% on a like-for-like basis excluding a negative perimeter effect of circa three points from the disposal of Euro Broadband Infrastructure (EBI) on 30 April 2021 and a positive currency effect of circa three points.Quarter-on-quarter  revenues of the five Operating Verticals were down by 0.7% like-for-like.Unless otherwise stated  all variations indicated hereunder are on a like-for-like basis  ie  at constant currency and perimeter.Broadcast (61% of revenues)Third Quarter Broadcast revenues amounted to ‚Ç¨173 million  down 6.8% year-on-year  representing an improvement in trend relative to the Second Quarter (-8.6% year-on-year). The revenue decline reflected predominantly the effect of the partial renewal of capacity with Nilesat at 7/8¬∞West  which is not offset by the resale of this capacity  and elsewhere  a slight erosion in the underlying business in Europe. Excluding the 7/8¬∞West impact  Broadcast revenues experienced a low-single-digit decline.Quarter-on-quarter  revenues were broadly stable with the slight  -0.8%  erosion reflecting the carryforward effect of the above-mentioned 7/8¬∞West headwind which impacted revenues from mid-October onwards. Revenues were flat excluding this item.Revenues are expected to remain broadly stable in the Fourth Quarter relative to the Third Quarter.Data & Professional Video (14% of revenues)Third Quarter Data & Professional Video revenues stood at ‚Ç¨40 million  down by 2.7% year-on-year.In Fixed Data  which represents two thirds of this application  improved volume trends are now offsetting most of the negative impact of competitive pressure.The Professional Video revenues trend saw a slight uptick  reflecting the phasing of a specific contract which is beneficial to the Second Half but neutral over the Full Year  as well as growth of occasional use.Quarter-on-quarter revenues were stable reflecting notably the above-mentioned Professional Video tailwind as well as the broad stabilization of Fixed Data.On the commercial front  a multi-year agreement was signed with Tuvalu Telecommunications Corporation for connectivity on the EUTELSAT 172B satellite to support the extension of corporate networks for government offices and businesses of the Tuvalu Islands.We expect this application to decline at a mid-single digit pace over the Full Fiscal Year  consistent with previous indications.Government Services (12% of revenues)Third Quarter Government Services revenues stood at ‚Ç¨35 million  down 11.3% year-on-year. This reflected the negative carry-forward effect of US Government renewals  driven by the withdrawal of troops from Afghanistan with in particular a renewal rate of only 75% in Fall 2021  as well as the end of life in stable orbit of EUTELSAT 174A.Quarter-on-quarter  revenues were down by 8.0% with the full effect of Fall 2021 renewals now in the quarterly base.On the commercial front  as anticipated in February  the latest renewal campaign with the US Government (Spring 2022) resulted in a below-average renewal rate estimated at above 70% reflecting the continued impact of the geopolitical context in the Middle East. Elsewhere  the commercialisation of EUTELSAT QUANTUM made further strong progress with five beams now secured for Government Services  of which three for incremental business and two to favour the renewal of existing business.In the Fourth Quarter  the full effect of Spring 2022 renewals relative to the Third Quarter should be largely offset by the ramp-up of new business on EUTELSAT QUANTUM.Fixed Broadband (6% of revenues)Third Quarter Fixed Broadband revenues stood at ‚Ç¨17 million  up 30.2% year-on-year on a like-for-like basis. They reflected the contribution from the wholesale agreements with TIM and Hispasat  the strong dynamic of our African operations and the ramp-up of the multi-beam agreement signed on EUTELSAT 65 West A with several Mexican service providers. Conversely  revenues also reflected the erosion of the legacy business of Bigblu Broadband on the KA-SAT satellite.Quarter-on-quarter  revenues were up by 7.7%.The favourable momentum in this application is set to continue into the Fourth Quarter.Mobile Connectivity (7% of revenues)Third Quarter Mobile Connectivity revenues stood at ‚Ç¨21 million  up 24.5% year-on-year. They reflected the carry-forward effect of the contract signed with Anuvu last year as well as the ongoing strong growth 4 of Maritime  driven by the ramp-up of contracts with service providers signed in recent years and by the agreement inked earlier this year on EUTELSAT QUANTUM with a customer in the Middle East.Quarter-on-quarter  revenues were up by 4.5%.On the commercial front  we continue to see a robust pipeline of business for maritime mobility highlighting both the strong demand in this vertical as well as the quality of our in-orbit resources and services.In the Fourth Quarter  growth is expected to decelerate as the comparison base will notably integrate the above-mentioned agreement with Anuvu.Other Revenues‚ÄòOther Revenues‚Äô amounted to ‚Ç¨2.1 million in the Third Quarter versus ‚Ç¨6.9 million a year earlier and ‚Ç¨1.0 million in the Second Quarter. They included a negative (‚Ç¨2.8) million impact from hedging operations compared to a positive impact of +‚Ç¨4.3 million last year and a negative impact of (‚Ç¨2) million in the Second Quarter.OPERATIONAL AND UTILIZED TRANSPONDERSThe number of operational transponders as of 31 March 2022 stood at 1 358 down by 22 units quarter-on-quarter  the latter reflecting principally the end of life in stable orbit of EUTELSAT 174A.The number of utilized transponders stood at 961  down 13 units quarter-on-quarter  reflecting principally the same effect as above as well as the Fall 2021 renewal campaign with the US Government.As a result  the fill rate stood at 70.7% compared with 69.5% a year ago and 70.6% at end-December 2021.31 March 2021 31 Dec. 2021 31 March 2022 Operational transponders6 1 366 1 380 1 358 Utilized transponders7 950 974 961 Fill rate 69.5% 70.6% 70.7% Note: Based on 36 MHz-equivalent transponders excluding high throughput capacityBACKLOGThe backlog stood at ‚Ç¨4.0 billion as of 31 March 2022 versus ‚Ç¨4.5 billion a year ago  and ‚Ç¨4.2 billion at end-December 2021  reflecting its natural consumption in the absence of major broadcast renewals this quarter.It was equivalent to 3.3 times 2020-21 revenues  with Broadcast representing 63%.31 March 2021 31 Dec. 2021 31 March 2022 Value of contracts (in billions of euros) 4.5 4.2 4.0 In years of annual revenues 3.5 3.4 3.3 Share of Broadcast 64% 64% 63% Note: The backlog represents future revenues from capacity or service agreements and can include contracts for satellites under procurement.Value of contracts (in billions of euros) 4.5 4.2 4.0 In years of annual revenues 3.5 3.4 3.3 Share of Broadcast 64% 64% 63%NINE MONTH REVENUESRevenues for the first Nine Months of FY 2021-22 stood at ‚Ç¨859 million  down by 7.6% on a reported basis and by 4.0% at constant currency and perimeter.Revenues of the five Operating Verticals (excluding ‚ÄòOther Revenues‚Äô) were down by 6.0% on a reported basis. They were down by 4.0% on a like-for-like basis excluding a positive effect from currency representing circa one point and a negative perimeter effect of circa three points from the disposal of Euro Broadband Infrastructure (EBI) on 30 April 2021 only partly offset by the consolidation of Bigblu Broadband Europe since 1st October 2020.At a 1.20 ‚Ç¨/$ rate (rate as per financial objectives) they stood at ‚Ç¨840 million.FINANCIAL OUTLOOKOn the back of the performance of the first Nine Months  we confirm our objective for the Full Year of Operating Vertical Revenues of between ‚Ç¨1 110 to ‚Ç¨1 130 million9.All other elements of the financial outlook are also confirmed:Cash Capex10 not exceeding ‚Ç¨400 million per annum for each of the next three fiscal years (FY 2021-22 / FY 2022-23 / FY 2023-24).Adjusted Discretionary Free Cash Flow of between ‚Ç¨400 million and ‚Ç¨430 million in FY 202122 at a ‚Ç¨/$ rate of 1.20. Adjusted Discretionary Free Cash Flow is expected to grow in FY 202223 and in FY 2023-24.The LEAP 2 plan aimed at generating ‚Ç¨20-25 million in annual savings by FY 2021-22.Commitment to a sound financial structure to support our solicited investment grade credit ratings targeting a medium-term net debt / EBITDA ratio of around 3x.The policy of a stable to progressive dividend is also reiterated.This outlook is based on the nominal deployment plan outlined below. It assumes no material deterioration of revenues generated from Russian customers.FLEET DEPLOYMENTNominal deployment programSince the last quarterly update in February 2022  there is no change in the nominal deployment program below.Changes in the fleet since 30 June 2021EUTELSAT QUANTUM was launched on 30 July 2021 and entered service in November 2021.The lease agreement for capacity on the YAHSAT 1B and Al Yah 3 satellites was terminated in the First Quarter of Fiscal Year 2021-22.EUTELSAT 48E  which was in inclined orbit  terminated its life in October 2021.EUTELSAT 174A is operating in inclined orbit since January 2022.EXPOSURE TO RUSSIAN CRISISAs disclosed in the latest Universal Registration Document  Eutelsat derived circa 6.3% of its revenues from Russian customers in Fiscal Year 2020-21 and has no material revenue exposure to Ukraine. The Group also leases capacity on four satellites owned by the Russian operator  RSCC  serving mostly the above-mentioned Russian customers and representing a net present value (included in Net Financial Debt) of ‚Ç¨322 million as of 31 December 2021.Furthermore  the OneWeb low-orbit constellation in which Eutelsat owns a 22.9% stake had to suspend the remaining six upcoming launches which were planned from Baikonur Cosmodrome. Since then  OneWeb entered into agreements with SpaceX and New Space India that will enable to resume satellite launches.Consistent with its Code of Ethics and as a provider of infrastructure globally Eutelsat upholds a commitment to neutrality and is therefore guided by sanctions and by the decisions of its competent regulatory bodies  which it strictly applies. In this context  Eutelsat immediately implemented EU Council Regulation 2022/350  suspending the broadcasting activities of Russian television stations such as Russia Today.Third Quarter 2021-22 revenues conference callA conference call will be held on Thursday  12 May 2022 at 18.30 CET / 17.30 GMT / 12.30 EST To connect to the call  please use the following numbers:‚Äì France: +33 (0) 1 76 77 25 07‚Äì UK: +44 (0) 330 165 4045‚Äì United States: +1 720-543-0214Access code: 5156191#Instant replay will be available from 12 May  22.30 CET to 19 May  22.30 CET on the following numbers:‚Äì France: +33 (0) 1 70 48 00 94‚Äì UK: + 44 (0) 20 3859 5407‚Äì United States: + 1 719 457 0820Access code: 5156191#Financial calendarNote: The financial calendar is provided for information purposes only. It is subject to change and will be regularly updated.3 August 2022: Full Year 2021-22 resultsAbout Eutelsat CommunicationsFounded in 1977  Eutelsat Communications is one of the world‚Äôs leading satellite operators. With a global fleet of satellites and associated ground infrastructure  Eutelsat enables clients across Video  Data  Government  Fixed and Mobile Broadband markets to communicate effectively to their customers  irrespective of their location. Around 7 000 television channels operated by leading media groups are broadcast by Eutelsat to one billion viewers equipped for DTH reception or connected to terrestrial networks. Committed to promoting all facets of sustainable development across its business activities  Eutelsat leverages its in-orbit resources to help bridge the digital divide while maintaining a safe and uncluttered space environment. As an attractive and socially responsible employer  Eutelsat assembles 1 200 men and women from 50 countries who are dedicated to delivering the highest quality of service. Eutelsat Communications is listed on the Euronext Paris Stock Exchange (ticker: ETL). For more about Eutelsat go to www.eutelsat.comDisclaimerThe forward-looking statements included herein are for illustrative purposes only and are based on management‚Äôs views and assumptions as of the date of this document.Such forward-looking statements involve known and unknown risks. For illustrative purposes only  such risks include but are not limited to: risks related to the health crisis; operational risks related to satellite failures or impaired satellite performance  or failure to roll out the deployment plan as planned and within the expected timeframe; risks related to the trend in the satellite telecommunications market resulting from increased competition or technological changes affecting the market; risks related to the international dimension of the Group‚Äôs customers and activities; risks related to the adoption of international rules on frequency coordination and financial risks related  inter alia  to the financial guarantee granted to the Intergovernmental Organization‚Äôs closed pension fund  and foreign exchange risk.Eutelsat Communications expressly disclaims any obligation or undertaking to update or revise any projections  forecasts or estimates contained in this document to reflect any change in events  conditions  assumptions or circumstances on which any such statements are based  unless so required by applicable law.The information contained in this document is not based on historical fact and should not be construed as a guarantee that the facts or data mentioned will occur. This information is based on data  assumptions and estimates that the Group considers as reasonable.Footnotes1. Like-for-like change.2. Change at constant currency and perimeter. The variation is calculated as follows: i) Q3 2021-22 USD revenues are converted at Q3 2020-21 rates; ii) the contribution of Eurobroadband Infrastructure (EBI) is excluded from Q3 2020-21 revenues; iii) Hedging impact is excluded from Other Revenues.3. Other Revenues include mainly the impact of EUR/USD revenue currency hedging  the provision of various consulting/engineering services and termination fees.4 Based on a ‚Ç¨/$ rate of 1.20.5 The share of each application as a percentage of total revenues is calculated excluding ‚ÄúOther Revenues‚Äù.6 Number of transponders on satellites in stable orbit  back-up capacity excluded.7 Number of transponders utilized on satellites in stable orbit.8 Change at constant currency and perimeter. The variation is calculated as follows: i) 9-months 2021-22 USD revenues are converted at 9-months 2020-21 rates; ii) the contribution of BigBlu Broadband Europe (BBB) from 1st July 2021 to 30 September 2021 is excluded from 9-months 2021-22 revenues; iii) the contribution of Eurobroadband Infrastructure (EBI) is excluded from 9-months 2020-21 revenues; iv) Hedging revenues are excluded from Other Revenues.9 Based on a ‚Ç¨/$ rate assumption of 1.20 and current perimeter.10 Including capital expenditure and payments under existing export credit facilities and other bank facilities financing investments as well as payments related to lease liabilities.,neutral,0.02,0.93,0.05,mixed,0.25,0.25,0.5,True,English,"['Third Quarter', 'Nine-month Revenues', 'Parabolic Arc', 'Eutelsat', 'Nine Month operating vertical revenues', 'Third Quarter operating vertical revenues', 'The Professional Video revenues trend', 'Nine Month Operating Verticals', 'Third Quarter Operating Verticals revenues', 'five Operating Verticals', 'Nine Month stage', 'Third Quarter Broadcast revenues', 'Professional Video tailwind', 'Chief Executive Officer', 'combined GEO/LEO solutions', 'Global distribution partnership', 'global distribution agreement', 'key connectivity verticals', 'Tuvalu Telecommunications Corporation', '7/8¬∞West headwind', 'EUTELSAT 172B satellite', 'Euro Broadband Infrastructure', 'THIRD QUARTER REVENUES5', '7/8¬∞West impact', 'Robust double-digit growth', 'positive currency effect', 'Eutelsat quantum satellite', 'strong double-digit growth', 'Broadcast revenue trend', 'Third Quarter Data', 'other financial objectives', 'negative perimeter effect', 'Nine Months', 'Broadcast trend', 'negative impact', 'Other Revenues', 'Strong growth', 'robust delivery', 'constant currency', 'revenue decline', 'multi-year agreement', 'Tuvalu Islands', 'Strong progress', 'Eutelsat PR', 'Eutelsat Communications', 'second quarter', 'Total revenues', 'Fourth Quarter', 'Fixed Broadband', 'carryforward effect', 'Mobile Connectivity', 'Eva Berneke', 'Government Services', 'geopolitical environment', 'Middle East', 'Recent months', 'meaningful progress', 'commercial front', 'competitive position', 'first step', 'significant potential', 'six beams', 'six months', 'coming months', 'operational synergies', 'three points', 'partial renewal', 'underlying business', 'low-single-digit decline', 'Fixed Data', 'two thirds', 'volume trends', 'competitive pressure', 'slight uptick', 'specific contract', 'Second Half', 'occasional use', 'broad stabilization', 'corporate networks', 'government offices', 'Euronext Paris', 'successful commercialization', 'two companies', 'slight erosion', 'entire capacity', 'Full Year', 'Credit', 'Airbus', 'expectations', '12 May', 'ISIN', 'ETL', 'improvement', 'OneWeb', 'development', 'HIGHLIGHTS', 'cooperation', 'basis', 'disposal', 'EBI', '30 April', 'variations', 'Nilesat', 'resale', 'Europe', 'mid-October', 'item', 'application', 'phasing', 'extension', 'businesses']",2022-05-22,2022-05-22,parabolicarc.com
5327,EuroNext,Google API,https://www.bollyinside.com/news/inflation-concerns-push-european-stock-prices-lower,Inflation concerns push European stock prices lower,1 day ago,On Wednesday  European markets fell  led by technology sectors  as fears of inflation and monetary policy tightening dampened optimism about China‚Äôs economic rebound  while UniCredit and Commerzbank climbed. After increasing a little more than 3% since Friday  the pan-European STOXX 600 index dipped 1.1 percent. Technology equities fell 2.7 percent  while basic materials sectors were hit by a drop in copper prices. Consumer price inflation in the United Kingdom surpassed 9% in April  the highest level on record  edging closer to the Bank of England‚Äôs estimate of above 10% later this year. ‚ÄúWorries about recession reared up again after UK inflation jumped to the highest level in 40 years ‚Äù said Susannah Streeter  senior investment and markets analyst at Hargreaves Landsdown. Euro zone inflation held steady at a record high 7.4% in April  driven by soaring fuel and food costs  the EU‚Äôs statistics agency said  lowering its estimate from a preliminary 7.5%.A rise in optimism on Tuesday  after falling COVID-19 cases in China drove hopes of more economic activity  proved short-lived. The STOXX 600 is in on course to end lower in May  having marked gains only in March this year. But with a 11% decline year-to-date  the index has still fared better than the S&P 500 and MSCI‚Äôs All Country index  which are down more than 14% over the same period.The European Central Bank is set to hike rates shortly after ending its bond-buying programme early in the third quarter  with the potential for further hikes in coming quarters  echoing a strategy similar to the U.S. Federal Reserve. ‚ÄúFor the first time overnight index swaps were pricing in that the ECB would hike by more than 100bps by their December meeting ‚Äù said Deutsche Bank strategist Jim Reid.In earnings  Euronext rose 3.9% on record quarterly revenue. Dutch bank ABN Amro topped profit estimates but shares fell 11.9% as it warned about the impact of the war in Ukraine. Siemens Gamesa jumped 12.6%  after sources said Siemens Energy is preparing to buy the remaining stake in the wind turbine maker. The stake is worth 3.14 billion euros ($3.31 billion). Germany‚Äôs Commerzbank AG rose 3.1%  while Italy‚Äôs UniCredit SpA gained 2% after a report spoke of scheduled merger talks before the potential deal was abandoned because of the Ukraine war. Holiday group TUI tumbled 12.6% after it announced a share sale to repay elements of a German state bailout it received during the pandemic.News Summary:,negative,0.06,0.45,0.49,negative,0.02,0.18,0.8,True,English,"['European stock prices', 'Inflation concerns', 'first time overnight index swaps', 'U.S. Federal Reserve', 'The European Central Bank', 'All Country index', 'wind turbine maker', 'German state bailout', 'pan-European STOXX 600 index', 'basic materials sectors', 'Deutsche Bank strategist', 'Consumer price inflation', 'Euro zone inflation', 'record quarterly revenue', 'The STOXX', 'S&P 500', 'European markets', 'technology sectors', 'Dutch bank', 'UK inflation', 'monetary policy', 'economic rebound', 'Technology equities', 'copper prices', 'United Kingdom', 'highest level', 'Susannah Streeter', 'senior investment', 'Hargreaves Landsdown', 'record high', 'food costs', 'statistics agency', 'COVID-19 cases', 'economic activity', 'same period', 'bond-buying programme', 'third quarter', 'coming quarters', 'December meeting', 'Jim Reid', 'ABN Amro', 'profit estimates', 'Siemens Gamesa', 'Siemens Energy', 'merger talks', 'Holiday group', 'share sale', 'News Summary', 'remaining stake', 'Commerzbank AG', 'UniCredit SpA', 'potential deal', 'Ukraine war', 'Wednesday', 'fears', 'optimism', 'China', 'Friday', 'drop', 'April', 'England', 'year', 'Worries', 'recession', 'analyst', 'fuel', 'rise', 'Tuesday', 'hopes', 'course', 'May', 'gains', 'March', '11% decline', 'MSCI', 'rates', 'hikes', 'strategy', 'ECB', '100bps', 'earnings', 'Euronext', 'shares', 'impact', 'sources', 'Germany', 'Italy', 'report', 'TUI', 'elements', 'pandemic', '14']",2022-05-21,2022-05-22,bollyinside.com
5328,EuroNext,Google API,https://www.directorstalkinterviews.com/public-storage---consensus-indicates-potential-28.5-upside/4121065611,Public Storage - Consensus Indicates Potential 28.5% Upside,23 hours ago,Public Storage with ticker code (PSA) have now 12 analysts in total covering the stock. The consensus rating is ‚ÄòBuy‚Äô. The target price ranges between 482 and 356 calculating the average target price we see 398. With the stocks previous close at 309.77 this indicates there is a potential upside of 28.5%. The day 50 moving average is 370.71 and the 200 day MA is 345.73. The market cap for the company is $55 077m. Find out more information at: https://www.publicstorage.comThe potential market cap would be $70 764m based on the market concensus.You can now share this on Stocktwits  just click the logo below and add the ticker in the text to be seen.Public Storage  a member of the S&P 500 and FT Global 500  is a REIT that primarily acquires  develops  owns and operates self-storage facilities. At September 30  2020  we had: (i) interests in 2 504 self-storage facilities located in 38 states with approximately 171 million net rentable square feet in the United States  (ii) an approximate 35% common equity interest in Shurgard Self Storage SA (Euronext Brussels:SHUR) which owned 239 self-storage facilities located in seven Western European nations with approximately 13 million net rentable square feet operated under the ¬ìShurgard¬î brand and (iii) an approximate 42% common equity interest in PS Business Parks (NYSE:PSB) which owned and operated approximately 28 million rentable square feet of commercial space at September 30  2020. Our headquarters are located in Glendale  California.,neutral,0.04,0.88,0.07,neutral,0.01,0.96,0.02,True,English,"['Public Storage', 'Consensus', 'Potential', '171 million net rentable square feet', '28 million rentable square feet', 'approximate 35% common equity interest', 'seven Western European nations', 'approximate 42% common equity interest', 'Shurgard Self Storage SA', 'PS Business Parks', 'average target price', 'potential market cap', 'Shurgard brand', 'Public Storage', 'potential upside', '50 moving average', 'market concensus', 'consensus rating', 'S&P 500', 'FT Global 500', 'self-storage facilities', 'Euronext Brussels', 'commercial space', 'ticker code', '200 day MA', 'United States', '13 million', '38 states', 'PSA', '12 analysts', 'total', 'stock', 'company', 'information', 'publicstorage', 'logo', 'text', 'member', 'REIT', 'September', 'interests', 'NYSE', 'PSB', 'headquarters', 'Glendale', 'California']",2022-05-22,2022-05-22,directorstalkinterviews.com
5329,EuroNext,Google API,https://www.totaltele.com/513261/Kerlink-and-partners-demonstrate-IoT-air-quality-monitoring-contact-tracing-system-that-shows-promise-for-controlling-viruses-spread,Kerlink and partners demonstrate IoT air-quality monitoring & contact-tracing system that shows promise for controlling viruses‚Äô spread,22 hours ago,Kerlink and Partners Deploy Internet of Things Project That Demonstrates How Building Owners Can Help Limit Covid-19 Transmission & Future Outbreaks of VirusesMay 5  2022  06:00 p.m. CEST ‚Äì Combining off-the-shelf IoT technologies and equipment with new mathematical models that simulated the propagation of Covid-19  a pilot solution at a leading Paris university hospital center has demonstrated how building managers in the future can limit the spread of viruses such as Covid-19.The eight-month trial in 2021 included nearly 200 students and about 20 staff volunteers who wore Bluetooth-enabled badges during their classes  labs and shifts at the Faculty of Medicine (medical school) at Kremlin-Bic√™tre AP-HP (Assistance Publique-H√¥pitaux de Paris).In addition to continuous monitoring of building air-quality  the system monitored occupants‚Äô movements and whereabouts using dedicated mathematical models developed by two Paris-Saclay University scientists. These models simulated the propagation of Covid-19 in the student population  based on contact-tracing matrices.‚ÄúThis made it possible to investigate the importance of actual contacts between individuals in the transmission process  and more generally to estimate the role of the population‚Äôs actions  such as gathering in ill-ventilated rooms and the length and type of communication ‚Äì casual short conversation or longer collaboration ‚Äì between individuals in the overall spread of the epidemic ‚Äù said Bertrand Maury  who along with colleague Sylvain Faure  created the algorithms. ‚ÄúThis evaluation clearly showed this IoT-based solution can help building managers in the future to limit the spread of viruses such as Covid-19.‚ÄùThe contact-tracing application in the buildings was paired with air-quality monitoring that included:‚Ä¢ CO2 levels in the premises in relation to occupancy rates and hours  and ventilation adjustments ‚Ä¢ Malfunctions in the ventilation or required maintenance of ventilation equipment  and‚Ä¢ Hourly renewal rate (HRR)  or complete renewal of the air in a room  which is a key performance indicator (KPI) monitored by building managers in their day-to-day operations.The contact-tracing matrices were inspired by an algorithm developed by France‚Äôs National Center for Scientific Research (CNRS) and Paris-Saclay University that defines epidemiological models for virus transmission. It also provides a first assessment of the influence of CO2 concentration as an indicator of poor air quality that may accelerate viral transmission  e.g. a CO2 level indicating insufficient indoor air renewal.The pilot project at Kremlin-Bic√™tre AP-HP has been validated by the clinical research unit of the Paris-Saclay Faculty of Medicine  while the protection of private data and the identities of the pilot-project participants fully complied with GDPR law.Prof. Olivier Lambotte  vice dean of the Faculty of Medicine at Kremlin-Bic√™tre AP-HP  said Covid-19 virus transmission and the desire to develop an ‚Äúimproved-alerting‚Äù tool based on epidemiologic models were the initial triggers for this demonstrator project and they have been successfully completed with air-quality monitoring through CO2-level analysis.‚ÄúAfter these initial results  the Faculty of Medicine will be able to refine its systems for combatting the spread of epidemics thanks to a better knowledge of the interactions between students and thanks to a mastery of air quality ‚Äù he said. ‚ÄúMathematical modeling of air renewal in a classroom or amphitheater allows us to estimate in advance the maximum number of people who can be present to maintain a CO2 level below a set threshold.‚ÄùThe system used technology jointly developed by Kerlink (AKLK ‚Äì FR0013156007)  a specialist in solutions dedicated to the Internet of Things (IoT)  Microshare  a provider of a leading data-management solutions for the IoT era  and Enless Wireless  a major manufacturer of intelligent self-powered sensors  communicating in radio mode and dedicated to energy performance & comfort applications in buildings.The LoRaWAN-based system used Kerlink Wanesy‚Ñ¢ Wave  a multi-purpose powered anchor ‚Äì combining Wi-Fi  BLE and LoRaWAN¬Æ  for contact-tracing data collection from Bluetooth badges ‚Äì and a Kerlink Wirnet‚Ñ¢ iFemtoCell indoor gateway to transmit the data to Microshare‚Äôs Universal Contact Tracing¬Æ application  which ensures end-to-end security  privacy and reliability for the delivery of critical information where it‚Äôs needed. The data it produces is GDPR-compliant and delivered through Microshare‚Äôs patent-pending rules and sharing engine to only appropriate  designated people in the organization at the right time. Enless Wireless provided the pilot project with easy-to-install and connect indoor air-quality transmitters with embedded CO2 sensors and high-performance D-type batteries.LoRa Alliance¬Æ and LoRaWAN¬Æ are marks used under license from the LoRa Alliance¬Æ.About KerlinkKerlink Group is a leading global provider of end-to-end connectivity solutions for designing  deploying  and operating public & private low power/wide area (LPWA) Internet of Things (IoT) networks. Its comprehensive product portfolio includes industrial-grade network equipment  best-of-breed network core  operations and management software  value-added applications and expert professional services  backed by strong R&D capabilities. Kerlink specializes in enabling future-proof intelligent IoT connectivity for three major domains: Smart City & Quality of Life ‚Äì urban operations  utilities & metering  retail & public places  infrastructure & hubs  health; Smart Building & Industry ‚Äì buildings & real estate  industry & manufacturing  asset monitoring & tracking  and Smart Agriculture & Environment ‚Äì precision agriculture  cattle monitoring & farming  environment & climate  and wildlife protection. More than 200 000 Kerlink installations have been rolled out with over 350 clients in 70 countries. Based in France  with subsidiaries in the US  Singapore  India and Japan  Kerlink is a co-founder and board member of the LoRa Alliance¬Æ and the uCIFI Alliance‚Ñ¢. It is listed on Euronext Growth Paris under the symbol ALKLK.For more information  visit www.kerlink.com or follow us on our social media - Twitter @kerlink_news  LinkedIn #Kerlink  YouTube ‚Äì KerlinkAbout MicroshareMicroshare¬Æ provides Smart Building data solutions at scale that enhance safety  wellness and sustainability  and drive cost savings and efficiencies across the world. Our EverSmart suite of solutions produces real-time insights where none previously existed in areas such as occupancy monitoring  energy consumption  customer satisfaction  environmental safety and more. Microshare is a proud member of the LoRa Alliance¬Æ. www.microshare.ioAbout Enless WirelessEnless Wireless is a leading automation and IoT French player in building energy efficiency & comfort for more than 12 years. It manufactures a catalogue of wireless radio sensors  based on the main LPWAN radio protocols LoRa  Sigfox  Wireless M-Bus. With Enless Wireless‚Äôs range of standalone wireless sensors LoRaWAN¬Æ  European system integrators can quickly and simply build their own private network using BACnet or Modbus protocols to connect to an PLC or their building‚Äôs IP network.Enless Wireless also manufactures ranges of Sigfox and LoRaWAN¬Æ devices which allow system integrators to build operated networks. Effective monitoring of the energy consumption  CO2  VOC  temperature ... with Low-Power / Ultra Long-Range products that are quick and easy to install is the first step to guarantee the safety and comfort of building‚Äôs occupants ... and the optimization of the energy bill!For more information  visit https://enless-wireless.com/en/(Enless Wireless is a certified ISO 9001 company)View more of the latest press releases from across the industry or post your company's news.,neutral,0.05,0.93,0.03,mixed,0.27,0.13,0.6,True,English,"['IoT air-quality monitoring', 'contact-tracing system', 'viruses‚Äô spread', 'Kerlink', 'partners', 'promise', 'Assistance Publique-H√¥pitaux de Paris', 'Kerlink Wirnet‚Ñ¢ iFemtoCell indoor gateway', 'leading Paris university hospital center', 'Universal Contact Tracing¬Æ application', 'two Paris-Saclay University scientists', 'insufficient indoor air renewal', 'Kremlin-Bic√™tre AP-HP', 'casual short conversation', 'colleague Sylvain Faure', 'Prof. Olivier Lambotte', 'leading data-management solutions', 'intelligent self-powered sensors', 'multi-purpose powered anchor', 'indoor air-quality transmitters', 'high-performance D-type batteries', 'Hourly renewal rate', 'leading global provider', 'clinical research unit', 'embedded CO2 sensors', 'Kerlink Wanesy‚Ñ¢ Wave', 'appropriate, designated people', 'poor air quality', 'new mathematical models', 'dedicated mathematical models', 'The LoRaWAN-based system', 'key performance indicator', 'end connectivity solutions', 'contact-tracing data collection', 'Covid-19 virus transmission', 'National Center', 'contact-tracing application', 'complete renewal', 'Mathematical modeling', 'Scientific Research', 'energy performance', 'contact-tracing matrices', 'Covid-19 Transmission', 'transmission process', 'CO2 levels', 'epidemiological models', 'CO2 concentration', 'viral transmission', 'epidemiologic models', 'Kerlink Group', 'pilot solution', 'eight-month trial', '20 staff volunteers', 'Bluetooth-enabled badges', 'medical school', 'continuous monitoring', 'occupants‚Äô movements', 'actual contacts', 'ill-ventilated rooms', 'longer collaboration', 'Bertrand Maury', 'IoT-based solution', 'air-quality monitoring', 'occupancy rates', 'first assessment', 'pilot project', 'pilot-project participants', 'GDPR law', 'vice dean', 'alerting‚Äù tool', 'initial triggers', 'demonstrator project', 'CO2-level analysis', 'initial results', 'maximum number', 'set threshold', 'Enless Wireless', 'major manufacturer', 'radio mode', 'comfort applications', 'Bluetooth badges', 'end security', 'critical information', 'patent-pending rules', 'right time', 'LoRa Alliance¬Æ', 'private l', 'Paris-Saclay Faculty', 'Building Owners', 'private data', 'IoT technologies', 'ventilation adjustments', 'IoT era', 'Things Project', 'student population', 'day operations', 'building managers', 'Future Outbreaks', 'overall spread', 'ventilation equipment', 'Partners', 'Internet', 'Viruses', 'CEST', 'shelf', 'propagation', '200 students', 'classes', 'labs', 'shifts', 'Medicine', 'addition', 'whereabouts', 'importance', 'individuals', 'role', 'actions', 'length', 'communication', 'epidemic', 'algorithms', 'evaluation', 'buildings', 'premises', 'relation', 'hours', 'Malfunctions', 'maintenance', 'HRR', 'KPI', 'France', 'CNRS', 'influence', 'protection', 'identities', 'desire', 'improved', 'systems', 'knowledge', 'mastery', 'classroom', 'amphitheater', 'advance', 'technology', 'AKLK', 'specialist', 'Microshare', 'Wi-Fi', 'LoRaWAN¬Æ', 'privacy', 'reliability', 'delivery', 'engine', 'organization', 'marks', 'license', 'public', '06:00']",2022-05-22,2022-05-22,totaltele.com
5330,EuroNext,Google API,https://pipelinereview.com/index.php/2022052180888/Antibodies/DA-Approves-Dupixent-dupilumab-as-First-Treatment-for-Adults-and-Children-Aged-12-and-Older-with-Eosinophilic-Esophagitis.html,FDA Approves Dupixent¬Æ (dupilumab) as First Treatment for Adults and Children Aged 12 and Older with Eosinophilic Esophagitis,1 day ago,"FDA Approves Dupixent¬Æ (dupilumab) as First Treatment for Adults and Children Aged 12 and Older with Eosinophilic EsophagitisDetails Category: Antibodies Published on Saturday  21 May 2022 11:43 Hits: 408Dupixent is the first and only medicine indicated to treat eosinophilic esophagitis in the United States; approval granted more than two months ahead of FDA's Priority Review action dateDupixent 300 mg weekly significantly improved signs and symptoms of eosinophilic esophagitis compared to placebo in a Phase 3 trial  underscoring the role of type 2 inflammation in this complex diseaseEosinophilic esophagitis is a chronic  progressive inflammatory disease driven by type 2 inflammation that damages the esophagus and prevents it from working properlyApproval represents first indication for Dupixent in a gastrointestinal disease and fourth disease indicated overallTARRYTOWN  NY  USA and PAROS  France I May 20  2022 I Regeneron Pharmaceuticals  Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has approved Dupixent¬Æ (dupilumab) 300 mg weekly to treat patients with eosinophilic esophagitis (EoE) aged 12 years and older  weighing at least 40 kg. With this approval  Dupixent becomes the first and only medicine specifically indicated to treat EoE in the United States. A regulatory filing for EoE is under review by the European Medicines Agency  and submissions to regulatory authorities in additional countries are planned by the end of 2022.""We have waited a long time for an FDA-approved treatment option for eosinophilic esophagitis ‚Äì an underdiagnosed and misunderstood disease of the esophagus that can make it extremely challenging and uncomfortable to eat and swallow "" said Mary Jo Strobel  Executive Director at the American Partnership for Eosinophilic Disorders (APFED). ""Before today  there were no approved treatments specifically for eosinophilic esophagitis  resulting in many people needing to maintain a strict diet and live in constant fear of food getting stuck in their throat. We welcome therapeutic options that can provide much-needed relief for these patients.""EoE is a chronic inflammatory disease driven by type 2 inflammation that damages the esophagus and prevents it from working properly. For people with EoE  swallowing even small amounts of food can be a painful and worrisome choking experience. They are often left to contend with the frustration and anxiety of a constantly evolving list of foods to avoid  a poor quality of life and a higher risk of depression. In cases where EoE causes the esophagus to narrow  forced and potentially painful dilation (physical expansion) of the esophagus may be needed. In severe cases  a feeding tube may be the only option to ensure proper caloric intake and adequate nutrition. About 160 000 patients are living with EoE in the U.S. These individuals are currently treated with therapies not specifically approved for the disease  of whom approximately 48 000 continue to experience symptoms despite multiple treatments.""It is gratifying that Dupixent  a medicine that we invented in our laboratories  is now approved in yet another disease marked by allergic or type 2 inflammation  namely eosinophilic esophagitis "" said George D. Yancopoulos  M.D.  Ph.D.  President and Chief Scientific Officer at Regeneron  and a principal inventor of Dupixent. ""Eosinophilic esophagitis can be debilitating for patients by inflaming and damaging the esophagus and limiting the ability to eat normally. Dupixent is the first and only medicine specifically indicated to treat eosinophilic esophagitis in the United States  and today's approval marks the fourth disease for which Dupixent is now indicated  reinforcing the promise of targeting IL-4 and IL-13 to effectively treat diseases with underlying type 2 inflammation.""""Eating regularly throughout the day is essential  yet significant difficulty swallowing food is a common symptom for people living with eosinophilic esophagitis. This can be incredibly upsetting and often leads to fear of pain or choking with every meal  every day "" said John Reed  M.D.  Ph.D.  Global Head of Research and Development at Sanofi. ""A large unmet need exists for treatment options that can provide meaningful symptom relief. Our Phase 3 clinical program showed that Dupixent weekly improved the ability to swallow and reduced inflammation in the esophagus  underscoring the role of type 2 inflammation in this complex disease. This is a landmark FDA approval for patients and their caregivers who now have a new option for treating this devastating disease.""The FDA approval is based on data from a Phase 3 trial with two parts (Part A and Part B) evaluating the efficacy and safety of Dupixent 300 mg weekly  compared to placebo  in patients aged 12 years and older with EoE  weighing at least 40 kg. After 24 weeks  patients treated with Dupixent 300 mg weekly experienced the following changes in Part A and Part B  respectively:69% and 64% reduction in disease symptoms from baseline compared to 32% and 41% for placebo. Disease symptoms were measured by the Dysphagia Symptom Questionnaire (DSQ)  where patients receiving Dupixent experienced a 21.9- and 23.8-point clinically meaningful improvement compared to 9.6- and 13.9-point improvement for placebo.Approximately 10 times as many patients achieved histological disease remission (peak esophageal intraepithelial eosinophil count of ‚â§6 eos/high power field [hpf]) compared to placebo: 60% and 59% compared to 5% and 6% of patients receiving placebo.The safety results were generally consistent with the known safety profile of Dupixent in its approved indications. Pooled adverse events from Parts A and B that were more commonly (‚â•2%) observed with Dupixent than placebo were injection site reactions (38% Dupixent  33% placebo)  upper respiratory tract infections (18% Dupixent  10% placebo)  arthralgia (2% Dupixent  1% placebo) and herpes viral infections (2% Dupixent  1% placebo).The FDA evaluated the Dupixent application under Priority Review  which is granted to therapies that have the potential to provide significant improvements in the treatment  diagnosis or prevention of serious conditions.About the Dupixent Eosinophilic Esophagitis TrialThe Phase 3 randomized  double-blind  placebo-controlled trial evaluated the efficacy and safety of Dupixent in patients aged 12 years and older with EoE. Part A enrolled 81 patients and evaluated Dupixent 300 mg weekly (42 treated with Dupixent and 39 with placebo). Part B enrolled 159 patients and evaluated Dupixent 300 mg weekly (80 with Dupixent and 79 with placebo).At 24 weeks  the co-primary endpoints in Parts A and B assessed patient-reported measures of difficulty swallowing (change from baseline in the DSQ on a 0-84 scale) and esophageal inflammation (proportion of patients achieving histological disease remission  defined as peak esophageal intraepithelial eosinophil count of ‚â§6 eos/hpf).About DupixentDupixent is administered as an injection under the skin (subcutaneous injection) at different injection sites. In patients aged 12 years and older  weighing at least 40 kg  with EoE  Dupixent is administered as a 300 mg dose with a pre-filled syringe or pen every week. Dupixent is intended for use under the guidance of a healthcare professional and can be given in a clinic or at home by self-administration after training by a healthcare professional. In children aged 12 to 17 years  Dupixent should be administered under the supervision of an adult.Dupixent  which was invented using Regeneron's proprietary VelocImmune¬Æ technology  is a fully human monoclonal antibody that inhibits the signaling of the interleukin-4 (IL-4) and interleukin-13 (IL-13) pathways and is not an immunosuppressant. The Dupixent development program has shown significant clinical benefit and a decrease in type 2 inflammation in Phase 3 trials  establishing that IL-4 and IL-13 are key and central drivers of the type 2 inflammation that plays a major role in multiple related and often co-morbid diseases. These diseases include approved indications for Dupixent such as asthma  atopic dermatitis  chronic rhinosinusitis with nasal polyposis (CRSwNP) and eosinophilic esophagitis  as well as investigational diseases such as prurigo nodularis.Regeneron and Sanofi are committed to helping patients in the U.S. who are prescribed Dupixent gain access to the medicine and receive the support they may need with the DUPIXENT MyWay¬Æ program. For more information  please call 1-844-DUPIXENT (1-844-387-4936) or visit www.DUPIXENT.com.Dupixent is also approved for use in certain patients with atopic dermatitis  asthma or CRSwNP in different age populations in a number of countries around the world  including the U.S.  European Union and Japan. Dupixent is currently approved for one or more of these indications in more than 60 countries  and more than 400 000 patients have been treated globally.About Regeneron's VelocImmune TechnologyRegeneron's VelocImmune technology utilizes a proprietary genetically engineered mouse platform endowed with a genetically humanized immune system to produce optimized fully human antibodies. When Regeneron's President and Chief Scientific Officer George D. Yancopoulos was a graduate student with his mentor Frederick W. Alt in 1985  they were the first to envision making such a genetically humanized mouse  and Regeneron has spent decades inventing and developing VelocImmune and related VelociSuite¬Æ technologies. Dr. Yancopoulos and his team have used VelocImmune technology to create approximately a quarter of all original  FDA-approved or authorized fully human monoclonal antibodies currently available. This includes Dupixent  REGEN-COV¬Æ (casirivimab and imdevimab)  Libtayo¬Æ (cemiplimab-rwlc)  Praluent¬Æ (alirocumab)  Kevzara¬Æ (sarilumab)  Evkeeza¬Æ (evinacumab-dgnb) and InmazebTM (atoltivimab  maftivimab  and odesivimab-ebgn).Dupilumab Development ProgramDupilumab is being jointly developed by Regeneron and Sanofi under a global collaboration agreement. To date  dupilumab has been studied across more than 60 clinical trials involving more than 10 000 patients with various chronic diseases driven in part by type 2 inflammation.In addition to the currently approved indications  Regeneron and Sanofi are studying dupilumab in a broad range of diseases driven by type 2 inflammation or other allergic processes including pediatric atopic dermatitis (6 months to 5 years of age  Phase 3)  hand and foot atopic dermatitis (Phase 3)  chronic obstructive pulmonary disease with evidence of type 2 inflammation (Phase 3)  pediatric eosinophilic esophagitis (Phase 3)  bullous pemphigoid (Phase 3)  prurigo nodularis (Phase 3)  chronic spontaneous urticaria (Phase 3)  chronic pruritis of unknown origin (Phase 3)  chronic inducible urticaria-cold (Phase 3)  chronic rhinosinusitis without nasal polyposis (Phase 3)  allergic fungal rhinosinusitis (Phase 3) and allergic bronchopulmonary aspergillosis (Phase 3). These potential uses of dupilumab are currently under clinical investigation  and the safety and efficacy in these conditions have not been fully evaluated by any regulatory authority.U.S. INDICATIONSDUPIXENT is a prescription medicine used:to treat adults and children 6 years of age and older with moderate-to-severe atopic dermatitis (eczema) that is not well controlled with prescription therapies used on the skin (topical)  or who cannot use topical therapies. DUPIXENT can be used with or without topical corticosteroids. It is not known if DUPIXENT is safe and effective in children with atopic dermatitis under 6 years of age.with other asthma medicines for the maintenance treatment of moderate-to-severe eosinophilic or oral steroid dependent asthma in adults and children 6 years of age and older whose asthma is not controlled with their current asthma medicines. DUPIXENT helps prevent severe asthma attacks (exacerbations) and can improve your breathing. DUPIXENT may also help reduce the amount of oral corticosteroids you need while preventing severe asthma attacks and improving your breathing. DUPIXENT is not used to treat sudden breathing problems. It is not known if DUPIXENT is safe and effective in children with asthma under 6 years of age.with other medicines for the maintenance treatment of chronic rhinosinusitis with nasal polyposis (CRSwNP) in adults whose disease is not controlled. It is not known if DUPIXENT is safe and effective in children with chronic rhinosinusitis with nasal polyposis under 18 years of age.to treat adults and children 12 years of age and older  who weigh at least 88 pounds (40 kg)  with eosinophilic esophagitis (EoE). It is not known if DUPIXENT is safe and effective in children with eosinophilic esophagitis under 12 years of age and who weigh at least 88 pounds (40 kg).Please see accompanying full Prescribing Information including Patient Information.About RegeneronRegeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for nearly 35 years by physician-scientists  our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development  almost all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases  allergic and inflammatory diseases  cancer  cardiovascular and metabolic diseases  pain  hematologic conditions  infectious diseases and rare diseases.Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite technologies  such as VelocImmune  which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies  and through ambitious research initiatives such as the Regeneron Genetics Center  which is conducting one of the largest genetics sequencing efforts in the world.For additional information about the company  please visit www.regeneron.com or follow @Regeneron on Twitter.About SanofiWe are an innovative global healthcare company  driven by one purpose: we chase the miracles of science to improve people's lives. Our team  across some 100 countries  is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally  while putting sustainability and social responsibility at the center of our ambitions.Sanofi is listed on EURONEXT: SAN and NASDAQ: SNY.SOURCE: Regeneron Pharmaceuticals",neutral,0.01,0.97,0.02,mixed,0.12,0.05,0.83,True,English,"['First Treatment', 'Eosinophilic Esophagitis', 'FDA', 'Dupixent¬Æ', 'dupilumab', 'Adults', 'Children', 'Priority Review action date', 'chronic, progressive inflammatory disease', 'Eosinophilic Esophagitis Details Category', 'European Medicines Agency', 'Mary Jo Strobel', 'chronic inflammatory disease', 'worrisome choking experience', 'proper caloric intake', 'Chief Scientific Officer', 'large unmet need', 'Phase 3 clinical program', 'George D. Yancopoulos', 'I Regeneron Pharmaceuticals', 'meaningful symptom relief', 'FDA-approved treatment option', 'underlying type 2 inflammation', 'U.S. Food', 'landmark FDA approval', 'The FDA approval', 'common symptom', 'Phase 3 trial', 'treatment options', 'M.D.', 'Ph.D.', 'Eosinophilic Disorders', 'United States', 'complex disease', 'gastrointestinal disease', 'fourth disease', 'Drug Administration', 'regulatory filing', 'regulatory authorities', 'additional countries', 'long time', 'misunderstood disease', 'Executive Director', 'American Partnership', 'strict diet', 'therapeutic options', 'small amounts', 'evolving list', 'poor quality', 'higher risk', 'physical expansion', 'feeding tube', 'adequate nutrition', 'principal inventor', 'significant difficulty', 'John Reed', 'Global Head', 'new option', 'devastating disease', 'two parts', 'following changes', 'Part A', 'Part B', 'First Treatment', 'constant fear', 'painful dilation', 'severe cases', 'multiple treatments', 'first indication', 'many people', 'disease symptoms', 'Dupixent 300 mg', 'Dupixent¬Æ', 'dupilumab', 'Adults', 'Children', 'Antibodies', 'Saturday', 'May', 'Hits', 'signs', 'placebo', 'role', 'esophagus', 'TARRYTOWN', 'USA', 'PAROS', 'France', 'NASDAQ', 'REGN', 'Sanofi', 'patients', 'EoE', '40 kg', 'submissions', 'end', 'APFED', 'today', 'throat', 'frustration', 'anxiety', 'foods', 'life', 'depression', 'forced', 'individuals', 'therapies', 'laboratories', 'allergic', 'President', 'ability', 'promise', 'IL-4', 'diseases', 'meal', 'Research', 'Development', 'caregivers', 'data', 'efficacy', 'safety', '24 weeks', '64% reduction', 'baseline']",2022-05-22,2022-05-22,pipelinereview.com
5331,EuroNext,Google API,https://www.crypto-reporter.com/newsfeed/inveniam-capital-partners-and-rialto-markets-announce-partnership-to-further-accelerate-adoption-of-middle-market-corporate-capital-raises-and-trading-of-private-market-securities-31525/,Inveniam Capital Partners and Rialto Markets Announce Partnership to Further Accelerate Adoption of Middle Market Corporate Capital Raises and Trading of Private Market Securities,1 day ago,MIAMI--(BUSINESS WIRE)--Inveniam Capital Partners (Inveniam)  and Rialto Markets (Rialto) announced today that Inveniam has made a capital investment in Rialto Markets and will support the burgeoning market with connectivity into its private market data eco-system. Inveniam via Inveniam.io  is the operating system for private market data that drives price discovery and automated waterfall calculations. Rialto Markets‚Äô fully functional alternative trading system (ATS) is unlocking secondary trading in the private securities market for retail and accredited investors.Shari Noonan  Rialto Markets CEO  who is leading this effort  offered  ‚ÄúTrading shares used to be restricted to certain companies that could afford to publicly list on a platform such as the New York Stock Exchange or Nasdaq  but a regulated secondary market for private company shares opens up trading and liquidity  and ultimately  price discovery.‚ÄùThe partnership arrives at a critical juncture for private market companies as in the 10 plus years prior to 2019  capital flowing into capital assets grew at 4 times the pace of public markets. After a down year in 2020  2021 saw U.S. private markets establish a new highwater mark for fundraising and as a result  more companies are staying private longer or bypassing going public. Additionally  in 2022  the U.S. Securities and Exchange Commission laid out a number of proposals including requirements for registered private funds advisors to distribute quarterly statements to private fund investors with a detailed accounting of all fees and expenses during the reporting period. Also in 2021  the Depository Trust & Clearing Corporation  announced its Digital Securities Management initiative  a platform that will  subject to regulatory approval  ‚Äúfor the first time  provide an industry-wide solution that offers common market infrastructure and standards across private markets.‚ÄùConcurrently  JP Morgan has embarked on ‚ÄúProject Bloom ‚Äù a platform intended to match start-ups with accredited investors. BlackRock  the world‚Äôs largest asset manager  is now advising its clients to consider moving away from the traditional 60/40 portfolio in favor of a 50/30/20 portfolio with 20% going into alternative  private market assets.Pat O‚ÄôMeara  founder and CEO of Inveniam  commented on the partnership  ‚ÄúIn order for there to be more fluid trading of private market securities  an entire ecosystem must be established. As such  today‚Äôs agreement with Rialto and Inveniam is an incredible advancement towards building that fully functioning ecosystem. This is great news for middle market companies in search capital and price discovery and is reminiscent of the development of the ECN markets in the ‚Äò90s.‚ÄùThe integration of Rialto into the Inveniam ecosystem will result in Rialto incorporating various components of digital securities data and real-time market data thereby delivering transparency and trust for market participants. Further  having diverse data flow via Ownera  and the industry‚Äôs FinP2P open-source routing and settlement protocol that interconnects the private markets seamlessly in a user friendly platform  will give the GPs direct access to better data systems  secondary markets for the exchange of alternative assets  and new novel forms of primary distribution will transform the role of fund administrators. Ownera interconnects asset sources and financial institutions to enable the trade of any digital security  from any source and tokenization platform  using any underlying technology.Tokeny  an enterprise-grade infrastructure provider that allows companies and financial actors to compliantly issue  transfer  and manage assets on blockchain  enabling them to improve asset liquidity  is also a part of the ecosystem. Tokeny‚Äôs involvment will allow not only auditable forms of compliance from the security to the investor  but it will also allow real-time surveillance of the underlying assets utilizing Inveniam.io.For further context on this agreement and the formation of this private market trading ecosystem  please visit Pat O‚ÄôMeara‚Äôs Medium post.For parties interested in how they can leverage Rialito and Inveniam for the capital formation and price discovery objectives  please contact:Support@RialtoMarkets.comInfo@Inveniam.ioAbout Rialto MarketsRialto Markets is a trusted ‚Äògo to‚Äô fully regulated broker dealer empowering companies to raise money through our unrivalled expertise in crowdfunding and institutional investment. We operate a fully compliant secondary market trading platform for buying and selling shares in private companies. Rialto Markets is a SEC and FINRA Regulated Broker Dealer (Rialto Primary) operating an Alternative Trading System (Rialto Secondary) for private securities including those issued as a Digital Asset Security. For more information go to: www.rialtomarkets.comAbout InveniamInveniam is a fintech company  headquartered in Miami  Florida  with offices in New York City and Detroit  MI. Founded in 2017  Inveniam has built Inveniam.io  a powerful technology platform that utilizes big data  AI  and blockchain technology to provide not only surety of data  but high-functioning use of that data in a distributed data ecosystem. Through Inveniam's platform  users can obtain real-time pricing of private  infrequently traded assets  accelerate diligence  accurately price assets  and identify buyers for those assets. Inveniam‚Äôs platform credentials data to commute trust throughout the global financial system. Inveniam holds numerous patents pertaining to the ingestion of data into smart contracts. For more information go to: www.inveniam.ioAbout Tokeny SolutionsTokeny provides an enterprise-grade infrastructure to allow companies and financial actors to compliantly issue  transfer  and manage assets on blockchain  enabling them to improve asset liquidity. Tokeny is a Blockchain 50 company recognized by CB Insights. They are backed by Euronext Group  Inveniam  Apex Group  and K20 Funds. To date  over $28 billion worth of assets have been tokenized using their solution. For more information go to: www.tokeny.comAbout OwneraOwnera is an institutional-grade digital securities routing and settlement network. Ownera interconnects asset sources and financial institutions to enable the trade of any digital security  from any source and tokenization platform  using any underlying technology. Ownera offers financial institution a unified wallet API that allows them to give their clients access to any of the digital securities. The Ownera technology aggregates and normalizes all the digital securities from all the sources  including onchain and offchain data  transactions and regulatory flows. Ownera is operating in the private market space  supporting tokenized real estate  funds  bonds and private company shares. The Ownera unified wallet API supports primary issuances  secondary trading and borrowing and lending. More details on: https://ownera.ioMedia Inquiries:Carly Cao3Points CommunicationsCarly@3PTsComm.com,neutral,0.02,0.97,0.01,mixed,0.65,0.11,0.25,True,English,"['Middle Market Corporate Capital Raises', 'Inveniam Capital Partners', 'Private Market Securities', 'Rialto Markets', 'Accelerate Adoption', 'Partnership', 'Trading', 'compliant secondary market trading platform', 'Digital Securities Management initiative', 'FINRA Regulated Broker Dealer', 'private market data eco-system', 'functional alternative trading system', 'New York Stock Exchange', 'U.S. private markets', 'alternative, private market assets', 'private market trading ecosystem', 'U.S. Securities', 'New York City', 'new highwater mark', 'private securities market', 'common market infrastructure', 'private market securities', 'automated waterfall calculations', 'private funds advisors', 'Pat O‚ÄôMeara', 'digital securities data', 'diverse data flow', 'FinP2P open-source routing', 'enterprise-grade infrastructure provider', 'new novel forms', 'real-time market data', 'largest asset manager', 'traditional 60/40 portfolio', 'user friendly platform', 'private market companies', 'middle market companies', 'private fund investors', 'powerful technology platform', 'private company shares', 'price discovery objectives', 'Digital Asset Security', 'Inveniam Capital Partners', 'Rialto Markets CEO', 'secondary trading', 'alternative assets', 'burgeoning market', 'market participants', 'operating system', 'data systems', 'digital security', 'Trading shares', 'fluid trading', 'secondary markets', 'private companies', '50/30/20 portfolio', 'fund administrators', 'asset sources', 'underlying technology', 'auditable forms', 'real-time surveillance', 'fintech company', 'Rialto Secondary', 'accredited investors', 'Exchange Commission', 'tokenization platform', 'public markets', 'ECN markets', 'capital assets', 'entire ecosystem', 'functioning ecosystem', 'underlying assets', 'BUSINESS WIRE', 'capital investment', 'Shari Noonan', 'critical juncture', '10 plus years', 'down year', 'quarterly statements', 'detailed accounting', 'reporting period', 'Clearing Corporation', 'regulatory approval', 'first time', 'industry-wide solution', 'JP Morgan', 'Project Bloom', 'incredible advancement', 'great news', 'search capital', 'various components', 'settlement protocol', 'direct access', 'primary distribution', 'financial institutions', 'financial actors', 'asset liquidity', 'Medium post', 'unrivalled expertise', 'institutional investment', 'Rialto Primary', 'Inveniam ecosystem', 'Depository Trust', 'capital formation', 'Inveniam.io', 'MIAMI', 'connectivity', 'ATS', 'retail', 'effort', 'Nasdaq', 'partnership', 'pace', 'fundraising', 'result', 'number', 'proposals', 'requirements', 'fees', 'expenses', 'standards', 'start-ups', 'BlackRock', 'world', 'clients', 'favor', 'founder', 'order', 'agreement', 'development', '90s', 'integration', 'transparency', 'Ownera', 'GPs', 'role', 'trade', 'Tokeny', 'blockchain', 'involvment', 'compliance', 'context', 'parties', 'Rialito', 'RialtoMarkets', 'Info', 'trusted', 'money', 'crowdfunding', 'Florida', 'offices', 'Detroit']",2022-05-20,2022-05-22,crypto-reporter.com
5332,EuroNext,Twitter API,Twitter,Why the London Stock Exchange and Euronext are moving their datacentres around https://t.co/0wLOiMNeKz,nan,Why the London Stock Exchange and Euronext are moving their datacentres around https://t.co/0wLOiMNeKz,neutral,0.05,0.88,0.07,neutral,0.05,0.88,0.07,True,English,"['London Stock Exchange', 'Euronext', 'datacentres', '0wLOiMNeKz', 'London Stock Exchange', 'Euronext', 'datacentres', '0wLOiMNeKz']",2022-05-22,2022-05-22,Unknown
5333,EuroNext,Twitter API,Twitter,Ex-Jefferies Execs  Former Euronext FX CTO To Launch Crypto Exchange - Blockworks https://t.co/nMsNqLqNKH,nan,Ex-Jefferies Execs  Former Euronext FX CTO To Launch Crypto Exchange - Blockworks https://t.co/nMsNqLqNKH,neutral,0.02,0.89,0.08,neutral,0.02,0.89,0.08,True,English,"['Former Euronext FX CTO', 'Ex-Jefferies Execs', 'Crypto Exchange', 'Blockworks', 'nMsNqLqNKH', 'Former Euronext FX CTO', 'Ex-Jefferies Execs', 'Crypto Exchange', 'Blockworks', 'nMsNqLqNKH']",2022-05-22,2022-05-22,Unknown
5334,EuroNext,Twitter API,Twitter,We‚Äôve created a progressive Certified Investment Banking Operations Professional course with Euronext Group that wi‚Ä¶ https://t.co/d4lsaJ9Xt9,nan,We‚Äôve created a progressive Certified Investment Banking Operations Professional course with Euronext Group that wi‚Ä¶ https://t.co/d4lsaJ9Xt9,neutral,0.04,0.95,0.01,neutral,0.04,0.95,0.01,True,English,"['progressive Certified Investment Banking Operations Professional course', 'Euronext Group', 'd4lsaJ9Xt9', 'progressive Certified Investment Banking Operations Professional course', 'Euronext Group', 'd4lsaJ9Xt9']",2022-05-22,2022-05-22,Unknown
5335,EuroNext,Twitter API,Twitter,Why the London Stock Exchange and Euronext are moving their datacentres around https://t.co/GCUIdF20AG,nan,Why the London Stock Exchange and Euronext are moving their datacentres around https://t.co/GCUIdF20AG,neutral,0.04,0.9,0.06,neutral,0.04,0.9,0.06,True,English,"['London Stock Exchange', 'Euronext', 'datacentres', 'GCUIdF20AG', 'London Stock Exchange', 'Euronext', 'datacentres', 'GCUIdF20AG']",2022-05-22,2022-05-22,Unknown
5336,EuroNext,Twitter API,Twitter,@ArchCordileone you are the epitome of the reason e Euronext I know has either left or are leaving the Catholic Chu‚Ä¶ https://t.co/VTctvBhe8N,nan,@ArchCordileone you are the epitome of the reason e Euronext I know has either left or are leaving the Catholic Chu‚Ä¶ https://t.co/VTctvBhe8N,negative,0.08,0.43,0.5,negative,0.08,0.43,0.5,True,English,"['Catholic Chu', 'ArchCordileone', 'epitome', 'reason', 'Euronext', 'VTctvBhe8N', 'Catholic Chu', 'ArchCordileone', 'epitome', 'reason', 'Euronext', 'VTctvBhe8N']",2022-05-21,2022-05-22,Unknown
